FLUDROCORTISONE ACETATE

FLUDROCORTISONE ACETATE was reported 2249 times

FLUDROCORTISONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DYSGLOBULINAEMIA 2 0.1000
1 BLOOD ANDROSTENEDIONE INCREASED 2 0.1000
2 17-HYDROXYPROGESTERONE INCREASED 3 0.0732
3 SERUM AMYLOID A PROTEIN INCREASED 9 0.0581
4 MYOFASCITIS 2 0.0241
5 BLOOD LACTIC ACID DECREASED 4 0.0233
6 ADDISON'S DISEASE 3 0.0208
7 ALLERGY TO IMMUNOGLOBULIN THERAPY 2 0.0183
8 CEREBRAL HYPOPERFUSION 8 0.0172
9 SUPINE HYPERTENSION 3 0.0159
10 ABDOMINAL WALL HAEMORRHAGE 4 0.0153
11 MULTIPLE SYSTEM ATROPHY 5 0.0142
12 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 15 0.0111
13 RENIN INCREASED 3 0.0110
14 CATHETER SITE NODULE 2 0.0105
15 WOUND NECROSIS 5 0.0104
16 RETINOPATHY HYPERTENSIVE 3 0.0099
17 ADRENOCORTICAL INSUFFICIENCY ACUTE 18 0.0092
18 EPILEPTIC ENCEPHALOPATHY 2 0.0090
19 ANDROGEN DEFICIENCY 3 0.0085
20 DENTURE WEARER 2 0.0077
21 BLOOD CORTICOTROPHIN INCREASED 2 0.0069
22 CORTISOL INCREASED 4 0.0064
23 INFUSION SITE DISCHARGE 11 0.0063
24 BLOOD CORTISOL DECREASED 4 0.0063
25 INFUSION SITE NODULE 6 0.0062
26 CATHETER SITE IRRITATION 2 0.0060
27 GIARDIASIS 2 0.0059
28 PHARYNGEAL HYPOAESTHESIA 5 0.0054
29 APNOEIC ATTACK 3 0.0053
30 BONE SCAN ABNORMAL 2 0.0047
31 INFUSION SITE BRUISING 10 0.0046
32 EHLERS-DANLOS SYNDROME 2 0.0043
33 ADRENAL NEOPLASM 2 0.0043
34 METAPLASIA 2 0.0042
35 SMALL FIBRE NEUROPATHY 3 0.0041
36 INFUSION SITE HAEMORRHAGE 13 0.0039
37 OCULAR VASCULAR DISORDER 3 0.0036
38 COVID-19 IMMUNISATION 3 0.0036
39 BURNOUT SYNDROME 2 0.0035
40 NASAL MUCOSAL DISORDER 2 0.0034
41 CAMPYLOBACTER GASTROENTERITIS 2 0.0034
42 INFUSION SITE WARMTH 4 0.0033
43 BLADDER SPASM 6 0.0032
44 LIVING IN RESIDENTIAL INSTITUTION 6 0.0032
45 ACTINOMYCOSIS 3 0.0031
46 BONE MARROW DEPRESSION 3 0.0031
47 PRODUCT EXPIRATION DATE ISSUE 4 0.0029
48 MAST CELL ACTIVATION SYNDROME 4 0.0028
49 BONE NEOPLASM 3 0.0028
50 INFUSION SITE MASS 3 0.0028
51 ON AND OFF PHENOMENON 15 0.0027
52 CATHETER SITE DISCHARGE 3 0.0027
53 INFUSION SITE PRURITUS 8 0.0025
54 CONTRAINDICATED PRODUCT PRESCRIBED 4 0.0024
55 INFUSION SITE IRRITATION 3 0.0023
56 ORTHOSTATIC HYPOTENSION 40 0.0023
57 HERPES OPHTHALMIC 3 0.0023
58 HYPOGLYCAEMIC SEIZURE 2 0.0022
59 METASTASES TO ADRENALS 2 0.0022
60 CHRONIC FATIGUE SYNDROME 3 0.0022
61 ADRENAL INSUFFICIENCY 26 0.0021
62 CATHETER SITE SWELLING 2 0.0021
63 ADRENAL DISORDER 4 0.0021
64 INFUSION SITE SWELLING 13 0.0021
65 HAEMANGIOMA OF LIVER 2 0.0020
66 LYMPHOCYTIC INFILTRATION 2 0.0020
67 NEPHROGENIC SYSTEMIC FIBROSIS 6 0.0020
68 AUTONOMIC NEUROPATHY 2 0.0020
69 NASAL INFLAMMATION 2 0.0019
70 METABOLIC ALKALOSIS 3 0.0019
71 JOINT CONTRACTURE 2 0.0019
72 PITUITARY TUMOUR BENIGN 3 0.0018
73 DEMENTIA WITH LEWY BODIES 2 0.0018
74 INFUSION SITE PAIN 23 0.0018
75 GASTROINTESTINAL BACTERIAL INFECTION 2 0.0017
76 CORTISOL DECREASED 2 0.0017
77 BREATH ODOUR 4 0.0016
78 FREEZING PHENOMENON 6 0.0016
79 ACUTE PSYCHOSIS 4 0.0016
80 AMPUTATION 2 0.0016
81 CATHETER SITE HAEMORRHAGE 4 0.0016
82 CEREBRAL ISCHAEMIA 8 0.0016
83 INFUSION SITE ERYTHEMA 13 0.0015
84 EYELID PAIN 3 0.0015
85 ABSCESS ORAL 2 0.0015
86 SKIN HYPERTROPHY 4 0.0014
87 EYE CONTUSION 3 0.0014
88 HYPERKINESIA 3 0.0014
89 INCORRECT DRUG ADMINISTRATION RATE 6 0.0014
90 GLUTEN SENSITIVITY 2 0.0014
91 CATHETER SITE ERYTHEMA 3 0.0014
92 BLADDER TRANSITIONAL CELL CARCINOMA 2 0.0014
93 PERIODONTITIS 3 0.0014
94 DIABETIC NEPHROPATHY 3 0.0014
95 INFUSION SITE INDURATION 2 0.0013
96 HYPOAESTHESIA FACIAL 2 0.0013
97 HYPERCAPNIA 4 0.0013
98 PARANASAL SINUS DISCOMFORT 5 0.0013
99 HAEMATOCRIT INCREASED 3 0.0013
100 FIBROSIS 4 0.0013
101 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
102 INFUSION SITE EXTRAVASATION 8 0.0013
103 BACTERIAL VAGINOSIS 2 0.0013
104 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
105 CEREBRAL ATROPHY 5 0.0013
106 DEVICE INFUSION ISSUE 3 0.0012
107 HYPERPARATHYROIDISM SECONDARY 3 0.0012
108 CEREBELLAR INFARCTION 2 0.0012
109 TONGUE DISCOMFORT 5 0.0012
110 DIABETIC RETINOPATHY 4 0.0012
111 ABDOMINAL INFECTION 3 0.0012
112 LAZINESS 2 0.0012
113 ACUTE SINUSITIS 2 0.0012
114 BLOOD CHLORIDE INCREASED 2 0.0012
115 CATHETER SITE PAIN 3 0.0012
116 KYPHOSIS 2 0.0011
117 MITRAL VALVE DISEASE 2 0.0011
118 ANIMAL BITE 3 0.0011
119 BLOOD POTASSIUM ABNORMAL 3 0.0011
120 BLOOD DISORDER 9 0.0011
121 STOMA SITE DISCHARGE 3 0.0011
122 METASTATIC RENAL CELL CARCINOMA 2 0.0011
123 DRUG DOSE TITRATION NOT PERFORMED 2 0.0011
124 CEREBROSPINAL FLUID LEAKAGE 2 0.0011
125 CHRONIC SINUSITIS 4 0.0011
126 BLOOD POTASSIUM DECREASED 32 0.0011
127 SKIN ABRASION 5 0.0011
128 MYELOPATHY 2 0.0011
129 VITAMIN B12 DECREASED 3 0.0010
130 FOOD ALLERGY 8 0.0010
131 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
132 COLOSTOMY 2 0.0010
133 HOSPICE CARE 10 0.0010
134 MASTICATION DISORDER 3 0.0010
135 FAILURE TO THRIVE 5 0.0010
136 BLADDER PAIN 3 0.0009
137 HYPOMAGNESAEMIA 13 0.0009
138 ABSCESS INTESTINAL 2 0.0009
139 HORDEOLUM 4 0.0009
140 AUTOIMMUNE DISORDER 9 0.0009
141 FACET JOINT SYNDROME 3 0.0009
142 CARDIAC FAILURE ACUTE 6 0.0009
143 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
144 MENINGITIS ASEPTIC 4 0.0009
145 CLOSTRIDIAL INFECTION 3 0.0009
146 DERMATITIS CONTACT 10 0.0009
147 BLOOD PRESSURE FLUCTUATION 21 0.0009
148 APLASIA PURE RED CELL 3 0.0009
149 INFUSION SITE INFECTION 2 0.0009
150 WEIGHT FLUCTUATION 9 0.0009
151 DISCOURAGEMENT 2 0.0009
152 INSURANCE ISSUE 13 0.0008
153 BRADYKINESIA 5 0.0008
154 ATAXIA 10 0.0008
155 VIRAL UPPER RESPIRATORY TRACT INFECTION 4 0.0008
156 PULSE ABSENT 4 0.0008
157 GASTROINTESTINAL OBSTRUCTION 2 0.0008
158 ATELECTASIS 8 0.0008
159 HYPOMANIA 3 0.0008
160 FLUID INTAKE REDUCED 4 0.0008
161 EOSINOPHILIA 14 0.0008
162 COMMUNICATION DISORDER 3 0.0008
163 HALLUCINATION 59 0.0008
164 NEURALGIA 19 0.0008
165 MEAN CELL VOLUME INCREASED 2 0.0008
166 CACHEXIA 4 0.0008
167 MEDICATION RESIDUE 2 0.0008
168 REHABILITATION THERAPY 3 0.0008
169 HAEMORRHAGIC STROKE 6 0.0008
170 MALABSORPTION 4 0.0008
171 POLYDIPSIA 3 0.0008
172 TOOTH INFECTION 10 0.0008
173 WALKING AID USER 5 0.0008
174 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
175 APPETITE DISORDER 5 0.0008
176 WRIST FRACTURE 9 0.0008
177 INTRACRANIAL ANEURYSM 3 0.0007
178 FOOD POISONING 4 0.0007
179 PRESYNCOPE 18 0.0007
180 POST PROCEDURAL INFECTION 6 0.0007
181 DECUBITUS ULCER 6 0.0007
182 NORMAL NEWBORN 4 0.0007
183 SKIN LACERATION 8 0.0007
184 BLOOD PHOSPHORUS INCREASED 2 0.0007
185 NONSPECIFIC REACTION 4 0.0007
186 BLOOD PRESSURE DECREASED 48 0.0007
187 DYSKINESIA 29 0.0007
188 LIGAMENT SPRAIN 7 0.0007
189 PERONEAL NERVE PALSY 4 0.0007
190 PURULENT DISCHARGE 3 0.0007
191 HYPOGLYCAEMIC COMA 2 0.0007
192 GROWTH RETARDATION 2 0.0007
193 ABDOMINAL ABSCESS 3 0.0007
194 VENTRICULAR EXTRASYSTOLES 7 0.0007
195 CREPITATIONS 2 0.0007
196 INFUSION SITE REACTION 2 0.0007
197 BLOOD CULTURE POSITIVE 2 0.0007
198 GENERAL SYMPTOM 5 0.0007
199 HEART RATE IRREGULAR 15 0.0007
200 PEMPHIGOID 5 0.0007
201 VASCULAR DEVICE INFECTION 3 0.0007
202 CRANIOCEREBRAL INJURY 2 0.0007
203 BLOOD THYROID STIMULATING HORMONE DECREASED 3 0.0007
204 ABDOMINAL HERNIA 3 0.0007
205 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
206 CANDIDA INFECTION 11 0.0007
207 UROSEPSIS 6 0.0006
208 NEPHROGENIC ANAEMIA 3 0.0006
209 ARTHRITIS INFECTIVE 3 0.0006
210 MULTIPLE MYELOMA 3 0.0006
211 BLOOD CREATININE DECREASED 2 0.0006
212 MULTIPLE ALLERGIES 5 0.0006
213 SKIN TIGHTNESS 3 0.0006
214 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
215 BLOOD ALBUMIN DECREASED 5 0.0006
216 SYNCOPE 63 0.0006
217 BILE DUCT STONE 2 0.0006
218 ATRIAL FLUTTER 5 0.0006
219 HALLUCINATION, VISUAL 13 0.0006
220 PARKINSONISM 6 0.0006
221 DYSARTHRIA 23 0.0006
222 SPEECH DISORDER 32 0.0006
223 POLYURIA 5 0.0006
224 ABNORMAL FAECES 5 0.0006
225 DIABETIC NEUROPATHY 3 0.0006
226 BLADDER DISORDER 6 0.0006
227 ELECTROLYTE IMBALANCE 7 0.0006
228 CYTOLYTIC HEPATITIS 2 0.0006
229 HYPOAESTHESIA ORAL 9 0.0006
230 POSTOPERATIVE WOUND INFECTION 4 0.0006
231 FEMORAL NECK FRACTURE 3 0.0006
232 DEPRESSION SUICIDAL 2 0.0006
233 MENTAL STATUS CHANGES 16 0.0006
234 HYPERTRANSAMINASAEMIA 4 0.0006
235 HYPERREFLEXIA 2 0.0006
236 EXTRASYSTOLES 4 0.0006
237 CAROTID ARTERY STENOSIS 2 0.0006
238 SEROTONIN SYNDROME 11 0.0006
239 DEMENTIA 16 0.0006
240 INTERNATIONAL NORMALISED RATIO INCREASED 16 0.0006
241 PNEUMONIA ASPIRATION 14 0.0006
242 GASTROINTESTINAL INFECTION 5 0.0006
243 GINGIVITIS 3 0.0006
244 GASTROENTERITIS VIRAL 10 0.0006
245 BLOOD PRESSURE ABNORMAL 11 0.0006
246 MONOCYTE COUNT INCREASED 2 0.0006
247 HYPONATRAEMIA 31 0.0005
248 DEVICE KINK 2 0.0005
249 GASTROENTERITIS 8 0.0005
250 LOSS OF CONSCIOUSNESS 70 0.0005
251 VENTRICULAR TACHYCARDIA 9 0.0005
252 ANOREXIA 7 0.0005
253 UNRESPONSIVE TO STIMULI 14 0.0005
254 HEART RATE ABNORMAL 3 0.0005
255 NEPHROPATHY 5 0.0005
256 BONE DENSITY ABNORMAL 2 0.0005
257 FISTULA 6 0.0005
258 EYE INFECTION 6 0.0005
259 AUTOIMMUNE THYROIDITIS 2 0.0005
260 SPINAL DISORDER 5 0.0005
261 HYPERTHERMIA 4 0.0005
262 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
263 ACIDOSIS 4 0.0005
264 CLAVICLE FRACTURE 2 0.0005
265 HERPES VIRUS INFECTION 3 0.0005
266 GINGIVAL DISORDER 2 0.0005
267 RALES 3 0.0005
268 APNOEA 4 0.0005
269 CONFUSIONAL STATE 83 0.0005
270 BODY TEMPERATURE DECREASED 5 0.0005
271 DISORIENTATION 20 0.0005
272 URINARY TRACT INFECTION 86 0.0005
273 ODYNOPHAGIA 3 0.0005
274 HYPERPHAGIA 2 0.0005
275 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
276 CANDIDIASIS 2 0.0005
277 HYPOKALAEMIA 23 0.0005
278 FRUSTRATION TOLERANCE DECREASED 4 0.0005
279 SEASONAL ALLERGY 7 0.0005
280 INTERNATIONAL NORMALISED RATIO DECREASED 2 0.0005
281 HYPOTENSION 99 0.0005
282 TENSION 3 0.0005
283 SLUGGISHNESS 5 0.0005
284 HICCUPS 4 0.0005
285 SPINAL COMPRESSION FRACTURE 4 0.0005
286 PRE-EXISTING CONDITION IMPROVED 3 0.0005
287 LIVE BIRTH 4 0.0005
288 PALLOR 13 0.0005
289 BLOOD SODIUM DECREASED 9 0.0005
290 DEHYDRATION 63 0.0005
291 SLEEP APNOEA SYNDROME 9 0.0005
292 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
293 CARDIAC FAILURE CHRONIC 2 0.0005
294 ABSCESS LIMB 2 0.0005
295 HEREDITARY ANGIOEDEMA 5 0.0005
296 DYSTONIA 9 0.0005
297 INCOHERENT 3 0.0005
298 MONOPLEGIA 2 0.0005
299 FALL 153 0.0005
300 SOMNAMBULISM 3 0.0005
301 MELANOCYTIC NAEVUS 2 0.0005
302 DYSGRAPHIA 3 0.0005
303 DENTAL CARIES 5 0.0005
304 DELUSION 7 0.0005
305 FUNGAL INFECTION 15 0.0004
306 SKIN INFECTION 5 0.0004
307 PRODUCT ADMINISTRATION ERROR 9 0.0004
308 BRONCHIECTASIS 3 0.0004
309 WRONG PRODUCT ADMINISTERED 3 0.0004
310 FEEDING DISORDER 9 0.0004
311 IMPAIRED GASTRIC EMPTYING 6 0.0004
312 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
313 URINARY INCONTINENCE 13 0.0004
314 END STAGE RENAL DISEASE 8 0.0004
315 BLOOD TESTOSTERONE DECREASED 3 0.0004
316 HAEMOGLOBIN INCREASED 2 0.0004
317 EAR DISORDER 2 0.0004
318 HIP FRACTURE 14 0.0004
319 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
320 GRAND MAL CONVULSION 4 0.0004
321 BLOOD PRESSURE INCREASED 66 0.0004
322 HYPOPHAGIA 11 0.0004
323 BACTERIAL INFECTION 8 0.0004
324 LACERATION 4 0.0004
325 LEUKAEMIA 4 0.0004
326 HYPOCALCAEMIA 8 0.0004
327 RESPIRATORY TRACT INFECTION 11 0.0004
328 VIRAL INFECTION 14 0.0004
329 GESTATIONAL DIABETES 2 0.0004
330 ENDOMETRIOSIS 2 0.0004
331 RECALLED PRODUCT ADMINISTERED 4 0.0004
332 MUSCLE RIGIDITY 5 0.0004
333 CHOLESTASIS 8 0.0004
334 GASTROINTESTINAL TOXICITY 2 0.0004
335 EAR INFECTION 11 0.0004
336 NOCTURIA 5 0.0004
337 CIRCULATORY COLLAPSE 7 0.0004
338 HEAD INJURY 13 0.0004
339 INTENTIONAL UNDERDOSE 3 0.0004
340 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
341 VITAMIN D DEFICIENCY 4 0.0004
342 OXYGEN SATURATION DECREASED 23 0.0004
343 SCAR 7 0.0004
344 COELIAC DISEASE 4 0.0004
345 ILLNESS 42 0.0004
346 ENCEPHALOPATHY 10 0.0004
347 SENSITIVE SKIN 3 0.0004
348 CARDIOMEGALY 5 0.0004
349 PSYCHIATRIC SYMPTOM 3 0.0004
350 HYPOPHOSPHATAEMIA 3 0.0004
351 MULTI-ORGAN FAILURE 7 0.0004
352 TOOTH DISORDER 9 0.0004
353 HYPERVOLAEMIA 2 0.0004
354 GENERALISED OEDEMA 5 0.0004
355 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
356 ABDOMINAL TENDERNESS 2 0.0004
357 SEIZURE 46 0.0004
358 EMPHYSEMA 4 0.0004
359 TROPONIN INCREASED 3 0.0004
360 AORTIC ANEURYSM 3 0.0004
361 TOOTH ABSCESS 4 0.0004
362 HYPOGLYCAEMIA 19 0.0004
363 LIPASE INCREASED 3 0.0004
364 PROCEDURAL COMPLICATION 3 0.0004
365 SINUSITIS 40 0.0004
366 RENAL FAILURE CHRONIC 3 0.0004
367 EAR DISCOMFORT 4 0.0004
368 UPPER RESPIRATORY TRACT INFECTION 18 0.0004
369 GAIT INABILITY 13 0.0004
370 OSTEOPOROSIS 16 0.0004
371 RIB FRACTURE 8 0.0004
372 MIGRAINE 37 0.0004
373 LEUKOCYTOSIS 7 0.0004
374 POOR VENOUS ACCESS 4 0.0004
375 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
376 RESTLESS LEGS SYNDROME 7 0.0004
377 HYPERSOMNIA 11 0.0004
378 BRAIN FOG 6 0.0004
379 PRODUCT USE COMPLAINT 6 0.0004
380 ANKYLOSING SPONDYLITIS 5 0.0004
381 BRONCHITIS 28 0.0004
382 SUDDEN DEATH 4 0.0004
383 COMPRESSION FRACTURE 2 0.0004
384 POOR QUALITY SLEEP 8 0.0004
385 BRUXISM 2 0.0004
386 PHARYNGITIS STREPTOCOCCAL 4 0.0004
387 BLOOD POTASSIUM INCREASED 6 0.0004
388 MUSCULOSKELETAL DISORDER 7 0.0004
389 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
390 HYDROCEPHALUS 2 0.0004
391 PULMONARY THROMBOSIS 4 0.0004
392 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
393 WOUND INFECTION 4 0.0004
394 FAECALOMA 2 0.0004
395 STAPHYLOCOCCAL INFECTION 12 0.0004
396 GASTROINTESTINAL PAIN 4 0.0004
397 MOBILITY DECREASED 26 0.0004
398 URINARY RETENTION 12 0.0004
399 MALNUTRITION 4 0.0004
400 KIDNEY INFECTION 7 0.0004
401 OCULAR DISCOMFORT 4 0.0004
402 DEVICE OCCLUSION 5 0.0004
403 BLOOD GLUCOSE DECREASED 17 0.0004
404 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
405 CHOLECYSTITIS ACUTE 2 0.0004
406 FACIAL PARALYSIS 3 0.0004
407 GRANULOCYTOPENIA 2 0.0004
408 VITAMIN D DECREASED 3 0.0004
409 PSEUDOMONAS INFECTION 3 0.0003
410 SKIN HYPERPIGMENTATION 3 0.0003
411 CEREBROVASCULAR ACCIDENT 59 0.0003
412 LETHARGY 20 0.0003
413 CARDIAC MURMUR 3 0.0003
414 DIPLOPIA 9 0.0003
415 CYSTITIS 11 0.0003
416 DYSSTASIA 10 0.0003
417 SPINAL OSTEOARTHRITIS 3 0.0003
418 BACTERAEMIA 4 0.0003
419 BALANCE DISORDER 29 0.0003
420 MYOCLONUS 4 0.0003
421 MACULAR DEGENERATION 4 0.0003
422 MYOSITIS 3 0.0003
423 THROAT TIGHTNESS 9 0.0003
424 BLOOD PRESSURE INADEQUATELY CONTROLLED 2 0.0003
425 INJECTION SITE VESICLES 2 0.0003
426 RENAL FAILURE ACUTE 14 0.0003
427 PATHOGEN RESISTANCE 3 0.0003
428 EATING DISORDER 7 0.0003
429 DERMATITIS ACNEIFORM 2 0.0003
430 EXOSTOSIS 3 0.0003
431 INCREASED TENDENCY TO BRUISE 3 0.0003
432 NEUROPATHY PERIPHERAL 31 0.0003
433 IRON DEFICIENCY ANAEMIA 3 0.0003
434 SMALL INTESTINAL OBSTRUCTION 4 0.0003
435 PRODUCT DISTRIBUTION ISSUE 3 0.0003
436 ANKLE FRACTURE 5 0.0003
437 FEMUR FRACTURE 10 0.0003
438 FAECES DISCOLOURED 7 0.0003
439 APPENDICITIS 3 0.0003
440 DIARRHOEA HAEMORRHAGIC 3 0.0003
441 PHOTOPHOBIA 6 0.0003
442 ARTERIOSCLEROSIS 3 0.0003
443 PAIN IN JAW 9 0.0003
444 INFUSION RELATED REACTION 21 0.0003
445 BLOOD URINE PRESENT 6 0.0003
446 PNEUMONIA 102 0.0003
447 RED BLOOD CELL COUNT DECREASED 9 0.0003
448 PRODUCTIVE COUGH 15 0.0003
449 HEART RATE DECREASED 11 0.0003
450 MOVEMENT DISORDER 10 0.0003
451 DRUG INTERACTION 49 0.0003
452 HYPERTENSION 65 0.0003
453 OSTEOARTHRITIS 13 0.0003
454 THERAPY CHANGE 3 0.0003
455 GASTRITIS 8 0.0003
456 IMMUNE SYSTEM DISORDER 4 0.0003
457 PULMONARY CONGESTION 4 0.0003
458 PRODUCT DOSE OMISSION ISSUE 89 0.0003
459 BRAIN INJURY 3 0.0003
460 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
461 METASTASES TO LYMPH NODES 2 0.0003
462 EYE SWELLING 11 0.0003
463 LIMB INJURY 8 0.0003
464 CHEST DISCOMFORT 30 0.0003
465 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
466 DYSPNOEA EXERTIONAL 11 0.0003
467 DYSPHONIA 17 0.0003
468 MUSCULAR WEAKNESS 33 0.0003
469 PARANOIA 5 0.0003
470 ENCEPHALITIS 2 0.0003
471 RHABDOMYOLYSIS 12 0.0003
472 POLLAKIURIA 12 0.0003
473 LOWER RESPIRATORY TRACT INFECTION 13 0.0003
474 COVID-19 50 0.0003
475 DIZZINESS 142 0.0003
476 DYSPHAGIA 27 0.0003
477 JOINT DISLOCATION 3 0.0003
478 NEPHROLITHIASIS 13 0.0003
479 TREMOR 47 0.0003
480 WEIGHT DECREASED 79 0.0003
481 DIVERTICULUM 2 0.0003
482 RETCHING 6 0.0003
483 INTENTIONAL DOSE OMISSION 8 0.0003
484 FEAR OF INJECTION 2 0.0003
485 CEREBRAL HAEMORRHAGE 10 0.0003
486 VERTIGO 17 0.0003
487 SEPSIS 31 0.0003
488 OSTEOMYELITIS 5 0.0003
489 BONE DISORDER 5 0.0003
490 MELAENA 6 0.0003
491 INJECTION SITE NODULE 3 0.0003
492 ASCITES 8 0.0003
493 THERAPEUTIC RESPONSE SHORTENED 9 0.0003
494 INFECTION 39 0.0003
495 CATARACT 16 0.0003
496 HEPATIC STEATOSIS 5 0.0003
497 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 14 0.0003
498 ORAL PAIN 6 0.0003
499 HYDRONEPHROSIS 2 0.0003
500 DECREASED APPETITE 62 0.0003
501 BLOOD CALCIUM DECREASED 3 0.0003
502 ANHEDONIA 7 0.0003
503 CHROMATURIA 6 0.0003
504 ECONOMIC PROBLEM 4 0.0003
505 OSTEOPENIA 4 0.0003
506 MICTURITION URGENCY 3 0.0003
507 HEART RATE INCREASED 26 0.0003
508 BOWEL MOVEMENT IRREGULARITY 2 0.0003
509 GASTROOESOPHAGEAL REFLUX DISEASE 21 0.0003
510 MUSCLE TWITCHING 6 0.0003
511 ACUTE RESPIRATORY FAILURE 5 0.0003
512 DEVICE RELATED INFECTION 4 0.0003
513 UNINTENTIONAL MEDICAL DEVICE REMOVAL 3 0.0003
514 GENERAL PHYSICAL HEALTH DETERIORATION 30 0.0003
515 OROPHARYNGEAL PAIN 24 0.0003
516 BLOOD BILIRUBIN INCREASED 7 0.0003
517 HAEMOLYSIS 2 0.0003
518 ATRIOVENTRICULAR BLOCK 2 0.0003
519 MUSCULOSKELETAL CHEST PAIN 4 0.0003
520 ASTHENIA 97 0.0003
521 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
522 EAR PAIN 5 0.0003
523 HAEMORRHOIDS 5 0.0003
524 CHOKING 5 0.0003
525 FLUID RETENTION 13 0.0003
526 HYPOXIA 9 0.0003
527 SOMNOLENCE 51 0.0003
528 FURUNCLE 2 0.0003
529 ANAEMIA 48 0.0003
530 GINGIVAL PAIN 2 0.0003
531 HYPERLIPIDAEMIA 3 0.0003
532 PRESCRIBED UNDERDOSE 5 0.0003
533 HYPOTHYROIDISM 8 0.0003
534 ELECTROCARDIOGRAM QT PROLONGED 9 0.0002
535 NIGHT SWEATS 8 0.0002
536 EYE PAIN 14 0.0002
537 FULL BLOOD COUNT DECREASED 5 0.0002
538 MYASTHENIA GRAVIS 2 0.0002
539 FIBROMYALGIA 6 0.0002
540 GAIT DISTURBANCE 47 0.0002
541 METASTASES TO BONE 4 0.0002
542 ESCHERICHIA INFECTION 2 0.0002
543 OSTEONECROSIS OF JAW 6 0.0002
544 INFLUENZA 27 0.0002
545 TOOTH LOSS 5 0.0002
546 EMBOLISM 2 0.0002
547 CYTOMEGALOVIRUS INFECTION 4 0.0002
548 HEMIPLEGIA 2 0.0002
549 DRY EYE 12 0.0002
550 AGGRESSION 12 0.0002
551 SECRETION DISCHARGE 3 0.0002
552 HAEMODIALYSIS 2 0.0002
553 OEDEMA PERIPHERAL 29 0.0002
554 UNEVALUABLE EVENT 18 0.0002
555 BRAIN OEDEMA 3 0.0002
556 ACUTE MYOCARDIAL INFARCTION 7 0.0002
557 PSYCHOTIC DISORDER 7 0.0002
558 MUSCLE ATROPHY 3 0.0002
559 ANGER 8 0.0002
560 CARDIAC FAILURE CONGESTIVE 19 0.0002
561 HEPATITIS 6 0.0002
562 CONSTIPATION 51 0.0002
563 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
564 APHASIA 7 0.0002
565 BLOOD MAGNESIUM DECREASED 2 0.0002
566 MYOPATHY 2 0.0002
567 NIGHTMARE 8 0.0002
568 MUSCLE STRAIN 2 0.0002
569 DELIRIUM 8 0.0002
570 SWELLING FACE 15 0.0002
571 SEPTIC SHOCK 10 0.0002
572 DEVICE USE ISSUE 4 0.0002
573 INTENTIONAL PRODUCT USE ISSUE 20 0.0002
574 BEDRIDDEN 3 0.0002
575 HYPERKALAEMIA 8 0.0002
576 ORAL CANDIDIASIS 3 0.0002
577 COLD SWEAT 4 0.0002
578 LUNG INFILTRATION 2 0.0002
579 PRODUCT SUBSTITUTION ISSUE 13 0.0002
580 STEVENS-JOHNSON SYNDROME 5 0.0002
581 ISCHAEMIC STROKE 4 0.0002
582 GALLBLADDER DISORDER 4 0.0002
583 MALIGNANT MELANOMA 3 0.0002
584 JOINT RANGE OF MOTION DECREASED 3 0.0002
585 QUALITY OF LIFE DECREASED 3 0.0002
586 PULMONARY OEDEMA 10 0.0002
587 GOUT 4 0.0002
588 PANCREATITIS ACUTE 5 0.0002
589 ANAL INCONTINENCE 2 0.0002
590 SINUS CONGESTION 3 0.0002
591 HOSPITALISATION 34 0.0002
592 TACHYPNOEA 3 0.0002
593 GINGIVAL BLEEDING 3 0.0002
594 HYPERGLYCAEMIA 8 0.0002
595 HIDRADENITIS 2 0.0002
596 BRAIN NEOPLASM 2 0.0002
597 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
598 DYSURIA 8 0.0002
599 MUSCULOSKELETAL STIFFNESS 19 0.0002
600 PYREXIA 75 0.0002
601 COGNITIVE DISORDER 10 0.0002
602 DEFORMITY 2 0.0002
603 DISCOMFORT 13 0.0002
604 BLINDNESS UNILATERAL 3 0.0002
605 GASTROINTESTINAL DISORDER 19 0.0002
606 SINUS TACHYCARDIA 3 0.0002
607 ARRHYTHMIA 10 0.0002
608 FOOT FRACTURE 4 0.0002
609 NERVOUSNESS 11 0.0002
610 POST PROCEDURAL COMPLICATION 4 0.0002
611 CONTUSION 20 0.0002
612 GLAUCOMA 4 0.0002
613 ANOSMIA 3 0.0002
614 HYPERCHOLESTEROLAEMIA 2 0.0002
615 LOCALISED INFECTION 5 0.0002
616 ERUCTATION 4 0.0002
617 PRESCRIBED OVERDOSE 4 0.0002
618 LIVER FUNCTION TEST ABNORMAL 6 0.0002
619 DIZZINESS POSTURAL 2 0.0002
620 FATIGUE 160 0.0002
621 SURGERY 12 0.0002
622 SKIN FISSURES 4 0.0002
623 HAEMATURIA 7 0.0002
624 INJECTION SITE URTICARIA 5 0.0002
625 DIARRHOEA 131 0.0002
626 ABDOMINAL DISCOMFORT 34 0.0002
627 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
628 SKIN HAEMORRHAGE 3 0.0002
629 VOMITING 95 0.0002
630 ABNORMAL BEHAVIOUR 8 0.0002
631 HAEMATOCRIT DECREASED 4 0.0002
632 PULMONARY MASS 3 0.0002
633 INABILITY TO AFFORD MEDICATION 2 0.0002
634 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
635 HYPOAESTHESIA 30 0.0002
636 HYPOTONIA 2 0.0002
637 HEPATIC FAILURE 6 0.0002
638 CELLULITIS 10 0.0002
639 PRODUCT PHYSICAL ISSUE 4 0.0002
640 BLOOD COUNT ABNORMAL 3 0.0002
641 DRY MOUTH 16 0.0002
642 TASTE DISORDER 4 0.0002
643 DEVICE FAILURE 3 0.0002
644 NECK PAIN 11 0.0002
645 PANCYTOPENIA 11 0.0002
646 EYELID PTOSIS 2 0.0002
647 MOTOR DYSFUNCTION 2 0.0002
648 NASOPHARYNGITIS 36 0.0002
649 INITIAL INSOMNIA 2 0.0002
650 THYROID DISORDER 3 0.0002
651 BACK PAIN 45 0.0002
652 RENAL DISORDER 9 0.0002
653 EJECTION FRACTION DECREASED 3 0.0002
654 BASAL CELL CARCINOMA 3 0.0002
655 MALAISE 84 0.0002
656 INSOMNIA 51 0.0002
657 TACHYCARDIA 17 0.0002
658 ROAD TRAFFIC ACCIDENT 8 0.0002
659 DEVICE ISSUE 17 0.0002
660 ABDOMINAL PAIN UPPER 39 0.0002
661 INCONTINENCE 2 0.0002
662 FULL BLOOD COUNT ABNORMAL 2 0.0002
663 RESPIRATORY TRACT CONGESTION 3 0.0002
664 ULCER 3 0.0002
665 BRADYCARDIA 10 0.0002
666 OBESITY 3 0.0002
667 ABSCESS 3 0.0002
668 BODY HEIGHT DECREASED 2 0.0002
669 THROMBOSIS 15 0.0002
670 ANXIETY 53 0.0002
671 COUGH 52 0.0002
672 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
673 DEVICE DISLOCATION 8 0.0002
674 BACK INJURY 2 0.0002
675 MENTAL DISORDER 8 0.0002
676 CHOLELITHIASIS 6 0.0002
677 ASPIRATION 2 0.0002
678 MANIA 3 0.0002
679 VISION BLURRED 25 0.0002
680 PLEURAL EFFUSION 11 0.0002
681 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
682 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
683 HEADACHE 113 0.0002
684 RENAL IMPAIRMENT 15 0.0002
685 RASH PAPULAR 4 0.0002
686 SNEEZING 4 0.0002
687 TYPE 2 DIABETES MELLITUS 6 0.0002
688 AGITATION 13 0.0002
689 NAUSEA 140 0.0002
690 ABDOMINAL PAIN 41 0.0002
691 CHOLECYSTECTOMY 2 0.0002
692 NEOPLASM 2 0.0002
693 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
694 DYSPNOEA 97 0.0002
695 FEELING ABNORMAL 41 0.0002
696 CHRONIC KIDNEY DISEASE 13 0.0002
697 LYMPHOCYTE COUNT DECREASED 3 0.0002
698 LYMPHADENOPATHY 6 0.0002
699 COVID-19 PNEUMONIA 2 0.0002
700 DRUG ERUPTION 3 0.0002
701 NEUTROPENIA 23 0.0002
702 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
703 BLOOD IRON DECREASED 2 0.0002
704 CHOLECYSTITIS 2 0.0002
705 CHEST PAIN 31 0.0002
706 RESPIRATORY DISORDER 5 0.0002
707 ADVERSE DRUG REACTION 15 0.0002
708 DISTURBANCE IN ATTENTION 9 0.0002
709 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
710 DEATH 143 0.0002
711 OEDEMA 9 0.0002
712 TOOTHACHE 3 0.0002
713 DRUG EFFECT INCOMPLETE 6 0.0002
714 ILL-DEFINED DISORDER 10 0.0002
715 TREATMENT NONCOMPLIANCE 9 0.0002
716 ATRIAL FIBRILLATION 16 0.0002
717 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 9 0.0002
718 MUSCLE SPASMS 30 0.0002
719 HYPERHIDROSIS 21 0.0002
720 DYSPEPSIA 16 0.0002
721 PERIPHERAL SWELLING 25 0.0002
722 INJECTION SITE EXTRAVASATION 2 0.0002
723 HYPERCALCAEMIA 2 0.0002
724 ABASIA 4 0.0002
725 LIMB DISCOMFORT 5 0.0002
726 CYST 2 0.0002
727 THINKING ABNORMAL 3 0.0002
728 MIDDLE INSOMNIA 3 0.0002
729 DISEASE PROGRESSION 19 0.0002
730 AGEUSIA 4 0.0002
731 MEMORY IMPAIRMENT 22 0.0002
732 PLATELET COUNT DECREASED 17 0.0002
733 DERMATITIS ALLERGIC 2 0.0002
734 FLATULENCE 9 0.0002
735 INFLUENZA LIKE ILLNESS 13 0.0002
736 PROTEINURIA 3 0.0002
737 FEELING JITTERY 3 0.0002
738 JOINT SWELLING 19 0.0002
739 CONVULSION 9 0.0002
740 INJECTION SITE IRRITATION 2 0.0002
741 HEPATIC CYTOLYSIS 2 0.0002
742 BURNING SENSATION 11 0.0002
743 ACUTE KIDNEY INJURY 24 0.0002
744 HERPES ZOSTER 9 0.0002
745 INJURY 11 0.0002
746 PULMONARY FIBROSIS 3 0.0002
747 MYDRIASIS 2 0.0002
748 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
749 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 28 0.0002
750 PALPITATIONS 18 0.0002
751 CHILLS 18 0.0002
752 PRODUCT DOSE OMISSION 10 0.0002
753 MUSCULOSKELETAL PAIN 8 0.0002
754 PARAESTHESIA 24 0.0002
755 JOINT STIFFNESS 4 0.0002
756 WEIGHT INCREASED 34 0.0002
757 RENAL FAILURE 20 0.0002
758 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
759 UPPER LIMB FRACTURE 3 0.0002
760 VISUAL ACUITY REDUCED 5 0.0002
761 EYE HAEMORRHAGE 2 0.0001
762 NEOPLASM MALIGNANT 10 0.0001
763 FEAR 4 0.0001
764 DEVICE BREAKAGE 6 0.0001
765 OCULAR HYPERAEMIA 7 0.0001
766 BODY TEMPERATURE INCREASED 3 0.0001
767 MOOD ALTERED 4 0.0001
768 AKATHISIA 2 0.0001
769 RASH ERYTHEMATOUS 7 0.0001
770 HAEMOGLOBIN DECREASED 15 0.0001
771 MATERNAL EXPOSURE DURING PREGNANCY 13 0.0001
772 INJECTION SITE WARMTH 3 0.0001
773 RESPIRATORY ARREST 4 0.0001
774 RESPIRATORY DISTRESS 4 0.0001
775 DIVERTICULITIS 4 0.0001
776 INTENTIONAL DRUG MISUSE 3 0.0001
777 CARDIO-RESPIRATORY ARREST 6 0.0001
778 HAEMOPTYSIS 4 0.0001
779 COORDINATION ABNORMAL 2 0.0001
780 BLOOD GLUCOSE INCREASED 27 0.0001
781 CARPAL TUNNEL SYNDROME 2 0.0001
782 BLISTER 8 0.0001
783 ARTHRALGIA 59 0.0001
784 PAIN 87 0.0001
785 LYMPHOPENIA 2 0.0001
786 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
787 DIALYSIS 2 0.0001
788 SKIN CANCER 3 0.0001
789 IMPAIRED QUALITY OF LIFE 2 0.0001
790 CARDIAC DISORDER 13 0.0001
791 PRURITUS GENERALISED 3 0.0001
792 CONDITION AGGRAVATED 42 0.0001
793 HYPOKINESIA 2 0.0001
794 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
795 PRODUCT PRESCRIBING ISSUE 3 0.0001
796 FLUID OVERLOAD 2 0.0001
797 C-REACTIVE PROTEIN INCREASED 5 0.0001
798 APATHY 2 0.0001
799 DEPRESSION 31 0.0001
800 NASAL CONGESTION 8 0.0001
801 PAIN IN EXTREMITY 40 0.0001
802 LABORATORY TEST ABNORMAL 4 0.0001
803 LIVER DISORDER 6 0.0001
804 TRANSAMINASES INCREASED 3 0.0001
805 RASH MACULO-PAPULAR 3 0.0001
806 RENAL INJURY 4 0.0001
807 IMMUNODEFICIENCY 2 0.0001
808 ABDOMINAL DISTENSION 14 0.0001
809 GLOSSODYNIA 3 0.0001
810 CARDIAC ARREST 11 0.0001
811 BONE LOSS 2 0.0001
812 PRODUCT USE ISSUE 25 0.0001
813 HOT FLUSH 10 0.0001
814 PANCREATITIS 7 0.0001
815 PRODUCT AVAILABILITY ISSUE 3 0.0001
816 DRUG DISPENSING ERROR 2 0.0001
817 WHITE BLOOD CELL COUNT INCREASED 5 0.0001
818 PERICARDIAL EFFUSION 3 0.0001
819 EMOTIONAL DISORDER 4 0.0001
820 MYALGIA 22 0.0001
821 LUNG INFECTION 2 0.0001
822 NERVOUS SYSTEM DISORDER 4 0.0001
823 PLASMA CELL MYELOMA 5 0.0001
824 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
825 DISEASE RECURRENCE 6 0.0001
826 THERAPY INTERRUPTED 9 0.0001
827 HALLUCINATION, AUDITORY 2 0.0001
828 OFF LABEL USE 110 0.0001
829 MOOD SWINGS 4 0.0001
830 DIABETIC KETOACIDOSIS 3 0.0001
831 CARDIAC FAILURE 10 0.0001
832 HAEMORRHAGE 13 0.0001
833 DRUG INTOLERANCE 12 0.0001
834 ASTHMA 14 0.0001
835 MUSCLE TIGHTNESS 2 0.0001
836 RESPIRATORY FAILURE 9 0.0001
837 AMNESIA 8 0.0001
838 NEUTROPHIL COUNT DECREASED 5 0.0001
839 EYE DISORDER 4 0.0001
840 LUNG NEOPLASM MALIGNANT 5 0.0001
841 RASH 53 0.0001
842 LEUKOPENIA 6 0.0001
843 WHITE BLOOD CELL COUNT DECREASED 13 0.0001
844 WITHDRAWAL SYNDROME 5 0.0001
845 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
846 CARDIOVASCULAR DISORDER 3 0.0001
847 HEMIPARESIS 2 0.0001
848 FLUSHING 12 0.0001
849 WHEEZING 7 0.0001
850 SWELLING 11 0.0001
851 INJECTION SITE SWELLING 9 0.0001
852 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
853 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
854 RECTAL HAEMORRHAGE 5 0.0001
855 INJECTION SITE REACTION 8 0.0001
856 THROMBOCYTOPENIA 13 0.0001
857 MUSCULOSKELETAL DISCOMFORT 2 0.0001
858 RASH GENERALISED 3 0.0001
859 THERAPEUTIC RESPONSE DECREASED 7 0.0001
860 DEAFNESS 3 0.0001
861 SEDATION 3 0.0001
862 PRURITUS 44 0.0001
863 ARTHRITIS 9 0.0001
864 RASH MACULAR 4 0.0001
865 FEELING HOT 7 0.0001
866 AMENORRHOEA 2 0.0001
867 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
868 METASTASES TO LIVER 2 0.0001
869 DEPRESSED MOOD 6 0.0001
870 SLEEP DISORDER 8 0.0001
871 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
872 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
873 HEAD DISCOMFORT 2 0.0001
874 CRYING 4 0.0001
875 SKIN LESION 3 0.0001
876 RESTLESSNESS 4 0.0001
877 MYOCARDIAL INFARCTION 19 0.0001
878 ABNORMAL DREAMS 3 0.0001
879 ADVERSE EVENT 10 0.0001
880 RHINORRHOEA 7 0.0001
881 PROCEDURAL PAIN 3 0.0001
882 MEDICATION ERROR 6 0.0001
883 FEELING COLD 3 0.0001
884 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5 0.0001
885 ERYTHEMA 22 0.0001
886 EPISTAXIS 8 0.0001
887 SKIN EXFOLIATION 9 0.0001
888 TARDIVE DYSKINESIA 3 0.0001
889 PULMONARY EMBOLISM 10 0.0001
890 DRY SKIN 14 0.0001
891 DRUG PRESCRIBING ERROR 2 0.0001
892 LOWER LIMB FRACTURE 2 0.0001
893 HERNIA 2 0.0001
894 MULTIPLE SCLEROSIS RELAPSE 7 0.0001
895 DISABILITY 2 0.0001
896 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
897 LACRIMATION INCREASED 3 0.0001
898 STOMATITIS 6 0.0001
899 PSORIATIC ARTHROPATHY 4 0.0001
900 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
901 INFLAMMATION 5 0.0001
902 SWOLLEN TONGUE 3 0.0001
903 ECZEMA 5 0.0001
904 JOINT INJURY 2 0.0001
905 IRRITABLE BOWEL SYNDROME 2 0.0001
906 DEEP VEIN THROMBOSIS 6 0.0001
907 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
908 RASH PRURITIC 5 0.0001
909 DEVICE LEAKAGE 4 0.0001
910 DIABETES MELLITUS 7 0.0001
911 INTERVERTEBRAL DISC PROTRUSION 2 0.0001
912 IMPAIRED HEALING 3 0.0001
913 HAEMATOCHEZIA 5 0.0001
914 SKIN DISORDER 3 0.0001
915 URTICARIA 15 0.0001
916 INJECTION SITE ERYTHEMA 11 0.0001
917 INCORRECT DOSE ADMINISTERED 20 0.0001
918 SKIN DISCOLOURATION 4 0.0001
919 NEOPLASM PROGRESSION 3 0.0001
920 HYPERSENSITIVITY 16 0.0001
921 BLOOD CHOLESTEROL INCREASED 4 0.0001
922 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
923 INTERSTITIAL LUNG DISEASE 4 0.0001
924 EMOTIONAL DISTRESS 10 0.0001
925 MENTAL IMPAIRMENT 2 0.0001
926 SUICIDE ATTEMPT 5 0.0001
927 LUNG DISORDER 4 0.0001
928 ALOPECIA 16 0.0001
929 DYSGEUSIA 6 0.0001
930 EXTRAPYRAMIDAL DISORDER 2 0.0001
931 INTESTINAL OBSTRUCTION 3 0.0001
932 COLITIS 3 0.0001
933 HAEMATEMESIS 2 0.0001
934 BLOOD CREATININE INCREASED 5 0.0001
935 SUICIDAL IDEATION 7 0.0001
936 APPLICATION SITE ERYTHEMA 2 0.0001
937 DERMATITIS ATOPIC 4 0.0001
938 INJECTION SITE PAIN 23 0.0001
939 FREQUENT BOWEL MOVEMENTS 2 0.0001
940 HEPATIC ENZYME INCREASED 5 0.0001
941 VISUAL IMPAIRMENT 9 0.0001
942 ARTHROPATHY 4 0.0001
943 TOXICITY TO VARIOUS AGENTS 12 0.0001
944 DRUG INEFFECTIVE 92 0.0001
945 ANGINA PECTORIS 2 0.0001
946 EYE IRRITATION 4 0.0001
947 VAGINAL HAEMORRHAGE 3 0.0001
948 NEEDLE ISSUE 2 0.0001
949 UNDERDOSE 5 0.0001
950 THROAT IRRITATION 3 0.0001
951 THERAPY NON-RESPONDER 3 0.0001
952 DRUG DOSE OMISSION 11 0.0001
953 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
954 CORONARY ARTERY DISEASE 2 0.0001
955 SKIN IRRITATION 3 0.0001
956 EPILEPSY 2 0.0001
957 OVERDOSE 14 0.0001
958 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
959 BONE DENSITY DECREASED 2 0.0001
960 COMA 3 0.0001
961 MULTIPLE SCLEROSIS 3 0.0001
962 METABOLIC ACIDOSIS 2 0.0001
963 FEBRILE NEUTROPENIA 4 0.0001
964 EXPIRED PRODUCT ADMINISTERED 2 0.0001
965 LIP SWELLING 2 0.0001
966 EYE PRURITUS 2 0.0001
967 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
968 DRUG EXPOSURE DURING PREGNANCY 2 0.0001
969 GASTRIC DISORDER 2 0.0001
970 ACCIDENTAL OVERDOSE 2 0.0001
971 ANAPHYLACTIC REACTION 3 0.0001
972 INJECTION SITE MASS 2 0.0001
973 RHEUMATOID ARTHRITIS 6 0.0001
974 BONE PAIN 3 0.0001
975 INJECTION SITE BRUISING 4 0.0001
976 IRRITABILITY 3 0.0000
977 NO ADVERSE EVENT 9 0.0000
978 EXTRA DOSE ADMINISTERED 2 0.0000
979 EXPOSURE DURING PREGNANCY 3 0.0000
980 HYPOACUSIS 2 0.0000
981 PRODUCT STORAGE ERROR 4 0.0000
982 DRUG WITHDRAWAL SYNDROME 4 0.0000
983 DEVICE DIFFICULT TO USE 3 0.0000
984 COLITIS ULCERATIVE 2 0.0000
985 BREAST CANCER 4 0.0000
986 DEVICE MALFUNCTION 3 0.0000
987 DRUG EFFECT DECREASED 2 0.0000
988 PRODUCT QUALITY ISSUE 5 0.0000
989 INTENTIONAL PRODUCT MISUSE 3 0.0000
990 DEVICE EXPULSION 2 0.0000
991 INJECTION SITE PRURITUS 2 0.0000